These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Non-small cell lung cancer with liver metastasis responsive to gemcitabine--a case report].
    Author: Sakurai T, Oura S, Yoshimasu T, Tanino H, Kokawa Y, Nakamura T, Matsuyama K, Naito Y.
    Journal: Gan To Kagaku Ryoho; 2001 May; 28(5):707-10. PubMed ID: 11383223.
    Abstract:
    A 56-year-old male patient underwent a right upper lobectomy and lymph node dissection for non-small cell lung cancer in March 1994. Multiple lung metastases in the right lung were found 45 months after the operation, and chemotherapy with docetaxel was administered. A liver metastasis was detected 11 months later, and it was refractory to docetaxel. Therefore, the patient was treated with cisplatin, mitomycin C and vinorelbine, which resulted in no change to the liver metastasis. He was next treated with gemcitabine, which resulted in a partial response of the liver metastasis. The adverse effects of gemcitabine were Grade 3 thrombocytopenia and Grade 2 neutropenia. The response duration for gemcitabine therapy was three months.
    [Abstract] [Full Text] [Related] [New Search]